scholarly article | Q13442814 |
P356 | DOI | 10.1002/SMLL.201402579 |
P698 | PubMed publication ID | 26460851 |
P50 | author | Jun Hon Pang | Q56938223 |
Alexander M Seifalian | Q57972310 | ||
Aaron Tan | Q63437581 | ||
P2093 | author name string | Jayakumar Rajadas | |
Brian G Cousins | |||
Yasmin Farhatnia | |||
Fatemeh Godarzi | |||
P2860 | cites work | Regulation of human endothelial progenitor cell maturation by polyurethane nanocomposites | Q48293158 |
Coronary stenting with the Genous™ Bio-Engineered R Stent™ in elderly patients. | Q50063858 | ||
Development of a novel endothelial cell-seeded endovascular stent for intracranial aneurysm therapy. | Q50909712 | ||
Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. | Q51006216 | ||
In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. | Q51420466 | ||
Vascular endothelial and smooth muscle cell culture on NaOH-treated poly(epsilon-caprolactone) films: a preliminary study for vascular graft development. | Q51466041 | ||
Development of novel covered stents using salmon collagen. | Q51745745 | ||
Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. | Q52002244 | ||
Polydopamine-mediated immobilization of multiple bioactive molecules for the development of functional vascular graft materials. | Q53363892 | ||
Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. | Q53401590 | ||
Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. | Q53473696 | ||
Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. | Q53560989 | ||
Arterial shear stress augments the differentiation of endothelial progenitor cells adhered to VEGF-bound surfaces. | Q54508683 | ||
Hydrodynamic shear-stress-dependent retention of endothelial and endothelial progenitor cells adhered to vascular endothelial growth factor-fixed surfaces. | Q54520820 | ||
Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis | Q56894441 | ||
Tailored functionalization of low-density polyethylene surfaces | Q57341381 | ||
Magnetic Tagging Increases Delivery of Circulating Progenitors in Vascular Injury | Q59291971 | ||
Concise review: Circulating endothelial progenitor cells for vascular medicine | Q27022889 | ||
VEGF signaling inside vascular endothelial cells and beyond | Q27687815 | ||
The biology of VEGF and its receptors | Q27860704 | ||
Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine | Q28751438 | ||
Mechanotransduction in vascular physiology and atherogenesis | Q30439086 | ||
The adhesive properties of endothelial cells on endovascular stent coated by substrates of poly-l-lysine and fibronectin | Q33235566 | ||
Selection and initial characterization of novel peptide ligands that bind specifically to human blood outgrowth endothelial cells | Q33291966 | ||
Selective endothelial cell attachment to peptide-modified terpolymers | Q33343879 | ||
VEGF targets the tumour cell | Q33573324 | ||
Linear shear conditioning improves vascular graft retention of adipose-derived stem cells by upregulation of the alpha5beta1 integrin | Q33608776 | ||
Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study | Q33820841 | ||
Modulation of human vascular endothelial cell behaviors by nanotopographic cues | Q34007293 | ||
The use of BDNF to enhance the patency rate of small-diameter tissue-engineered blood vessels through stem cell homing mechanisms | Q34048459 | ||
Improved endothelialization of NiTi alloy by VEGF functionalized nanocoating | Q34183651 | ||
Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. | Q34236181 | ||
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent | Q34334903 | ||
Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications | Q34385892 | ||
In situ re-endothelialization via multifunctional nanoscaffolds | Q34419883 | ||
Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering | Q34600436 | ||
Cell-SELEX Technology | Q34628815 | ||
Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review | Q34843553 | ||
Potential capacity of aptamers to trigger immune activation in human blood. | Q34918601 | ||
An anti-CD34 antibody-functionalized clinical-grade POSS-PCU nanocomposite polymer for cardiovascular stent coating applications: a preliminary assessment of endothelial progenitor cell capture and hemocompatibility. | Q35015083 | ||
Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model | Q35079541 | ||
Endothelial progenitor cells: mobilization, differentiation, and homing | Q35114634 | ||
Peptide-mediated selective adhesion of smooth muscle and endothelial cells in microfluidic shear flow | Q40156512 | ||
Evolving the use of peptides as components of biomaterials | Q42225643 | ||
Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization | Q42278869 | ||
Endothelial cells derived from circulating progenitors as an effective source to functional endothelialization of NaOH-treated poly(epsilon-caprolactone) films. | Q42524491 | ||
A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion | Q42591271 | ||
The immobilization of basic fibroblast growth factor on plasma-treated poly(lactide-co-glycolide). | Q42816192 | ||
Functionalization of the surface of electrospun poly(epsilon-caprolactone) mats using zwitterionic poly(carboxybetaine methacrylate) and cell-specific peptide for endothelial progenitor cells capture | Q42816963 | ||
A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices | Q42926908 | ||
Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix | Q43077176 | ||
In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer | Q43165218 | ||
Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization | Q43175040 | ||
Influence of a layer-by-layer-assembled multilayer of anti-CD34 antibody, vascular endothelial growth factor, and heparin on the endothelialization and anticoagulation of titanium surface | Q43464632 | ||
Dual functionalization of poly(ε-caprolactone) film surface through supramolecular assembly with the aim of promoting in situ endothelial progenitor cell attachment on vascular grafts | Q43482666 | ||
Peptide-grafted poly(ethylene glycol) hydrogels support dynamic adhesion of endothelial progenitor cells | Q43688346 | ||
Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. | Q43703136 | ||
Duration of dual antiplatelet therapy and outcomes after coronary stenting with the Genous™ bio-engineered R stent™ in patients from the e-HEALING registry | Q43947420 | ||
Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study | Q44222025 | ||
Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model | Q44441268 | ||
Surface design for in situ capture of endothelial progenitor cells: VEGF-bound surface architecture and behaviors of cultured mononuclear cells | Q44565677 | ||
Bioabsorbable drug eluting stent: winner or sinner? | Q44800763 | ||
Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent | Q44941164 | ||
Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins? | Q45453643 | ||
First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model. | Q45918764 | ||
Surface modification of poly(L-lactic acid) with biomolecules to promote endothelialization | Q46080674 | ||
Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces | Q46154659 | ||
The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent | Q46168270 | ||
Superparamagnetic iron oxide nanoparticles impair endothelial integrity and inhibit nitric oxide production. | Q46278133 | ||
Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry | Q46489660 | ||
Introducing amine functionalities on a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) surface: comparing the use of ammonia plasma treatment and ethylenediamine aminolysis. | Q46939213 | ||
Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody | Q47648033 | ||
Vascular endothelial cells on two-and three-dimensional fibrin assemblies for biomaterial coatings | Q47705854 | ||
Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. | Q47823271 | ||
Coated prostheses are associated with prolonged inflammation in aortic surgery: a cost analysis | Q47972207 | ||
Synthetic ePTFE grafts coated with an anti-CD133 antibody-functionalized heparin/collagen multilayer with rapid in vivo endothelialization properties | Q47998108 | ||
Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells. | Q35888570 | ||
Endothelial function: cardiac events | Q36019119 | ||
Fabrication of small-diameter vascular scaffolds by heparin-bonded P(LLA-CL) composite nanofibers to improve graft patency | Q36925659 | ||
Nitinol-based nanotubular coatings for the modulation of human vascular cell function | Q37095166 | ||
Investigating surface topology and cyclic-RGD peptide functionalization on vascular endothelialization | Q37157758 | ||
Assessing identity, phenotype, and fate of endothelial progenitor cells | Q37231424 | ||
Endothelial progenitor cells in vascular repair and remodeling | Q37250272 | ||
A fibronectin-fibrinogen-tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell function | Q37294925 | ||
Endothelial progenitor cells - hype or hope? | Q37389638 | ||
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis | Q37502920 | ||
Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization--a review of current strategies. | Q37625141 | ||
The endothelial cell in health and disease: its function, dysfunction, measurement and therapy | Q37662195 | ||
The role of endothelial cells and their progenitors in intimal hyperplasia | Q37702032 | ||
Engineering nanocomposite materials for cancer therapy | Q37794066 | ||
Micro-/nano-engineered cellular responses for soft tissue engineering and biomedical applications. | Q37871566 | ||
Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents | Q37919640 | ||
Endothelial progenitor cell capture stent: safety and effectiveness | Q38011752 | ||
The importance of the endothelium in atherothrombosis and coronary stenting | Q38012002 | ||
Human endothelial progenitor cells | Q38023863 | ||
Nitric oxide donors for cardiovascular implant applications | Q38058487 | ||
Plasma-based biofunctionalization of vascular implants | Q38068246 | ||
Antibody orientation on biosensor surfaces: a minireview | Q38075775 | ||
Inception to actualization: next generation coronary stent coatings incorporating nanotechnology. | Q38078738 | ||
New concepts in the design of drug-eluting coronary stents | Q38082647 | ||
Optical coherence tomography for evaluation of coronary stents in vivo. | Q38101964 | ||
Biological responses in stented arteries | Q38106014 | ||
Luminal surface engineering, 'micro and nanopatterning': potential for self endothelialising vascular grafts? | Q38197007 | ||
Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells | Q38299965 | ||
Solid-state protein formulations | Q38309879 | ||
The effect of RGD fluorosurfactant polymer modification of ePTFE on endothelial cell adhesion, growth, and function | Q39234711 | ||
Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation | Q39478673 | ||
Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface. | Q39480785 | ||
A biodegradable and biocompatible regular nanopattern for large-scale selective cell growth | Q39633149 | ||
Antibody covalent immobilization on carbon nanotubes and assessment of antigen binding | Q39747061 | ||
Fibronectin-mediated endothelialisation of chitosan porous matrices | Q39823852 | ||
Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. Six-month clinical, angiographic, and IVUS follow-up | Q39869194 | ||
Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall. | Q40115448 | ||
P433 | issue | 47 | |
P304 | page(s) | 6248-6264 | |
P577 | publication date | 2015-10-13 | |
P1433 | published in | Small | Q3486838 |
P1476 | title | In situ Endothelialization: Bioengineering Considerations to Translation | |
P478 | volume | 11 |
Q30831562 | A Novel Bioreactor System for the Assessment of Endothelialization on Deformable Surfaces. |
Q39165018 | Cardiovascular Bio-Engineering: Current State of the Art. |
Q33849581 | Continuously Grooved Stent Struts for Enhanced Endothelial Cell Seeding |
Q64119605 | Electrospun polycaprolactone/collagen nanofibers cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/hydroxysuccinimide and genipin facilitate endothelial cell regeneration and may be a promising candidate for vascular scaffolds |
Q47990120 | Low-thrombogenic fibrin-heparin coating promotes in vitro endothelialization. |
Q59791617 | Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits |
Q37258891 | Substrate Stiffness Combined with Hepatocyte Growth Factor Modulates Endothelial Cell Behavior. |
Q64984059 | Surface patterning of a novel PEG-functionalized poly-l-lactide polymer to improve its biocompatibility: Applications to bioresorbable vascular stents. |
Q55349297 | VV extracorporeal life support for the Third Millennium: will we need anticoagulation? |
Q38696893 | Vascular Mechanobiology: Towards Control of In Situ Regeneration. |
Search more.